PTGS2 and malignant colon neoplasm: It was shown that COX-2 inhibition (either by genetic or pharmacological means) might be effective in the inhibition of tumorigenic processes; moreover, several animal and human models showed that NSAIDs and coxibs might be useful in preventing the experimental colon cancer model [42,43,44,45].